Index
Our project aimed to engineer B. subtilis natto strains that enhance nattokinase (NK) production, an extracellular fibrinolytic enzyme against blood-clotting thrombosis. As we carefully considered the technical aspects of this research, the engineering decisions were based on published results, computational modeling, and empirical findings derived from our laboratory’s investigations. Within this segment of our wiki, we plan to clarify the fundamental DBTL rationales behind our laboratory activities to successfully genetically modify natto bacteria.
The primary goal of our project is to create a plasmid with
NK-coding gene, aprE, and introduce the plasmid into
B. subtilis natto. This plasmid, combined with the
preexisting metabolic pathway in natto bacteria, will enhance NK
production rate and ultimately enable its overproduction to be
utilized as an antithrombotic agent.
However, through literature search and human-practice activities
with experts, we figured that a few uncertainties for this project
significantly affect the success of this objective.
1. B. subtilis natto has low natural transformation
efficiency.[1] Because of this, its not well-established.[2]
Currently, the most popular way to engineer this chassis is by
conjugational transfer.
Thus, our objective plasmid will initially be transformed into model
organism B. subtilis
168, and subsequently into
B. subtilis natto
BEST195 via
conjugational transfer.
2. Chromosomal DNA of B. subtilis natto is highly homologous to B. subtilis 168, and when genetically engineering B. subtilis natto, parts such as promoters and plasmids are compatible with those of B. subtilis. However, despite B. subtilis being a model organism for Gram-positive bacteria in laboratories, its iGEM registry parts are still small, with relatively few working parts. This was especially a problem for our project of overproducing a material in B. subtilis natto, as two strong constitutive promoters for B. subtilis on the registry, BBa_K780003 and BBa_K090504, both provide little documentation of its functionality nor results. Finding suitable parts was also a problem when finding shuttle vector plasmid backbones and short terminators that could be used for B. subtilis.
The goal of the project is achieved by inserting aprE, the
nattokinase encoding gene, into a shuttle vector plasmid and
eventually transform them into
B. subtilis natto BEST195.
Thus, our objective plasmid will initially be transformed into
E. coli DH5α for proliferation, extracted/transferred into
E. coli C600 (which has the wild-type recA gene
for plasmid multimerization), then into highly genetically amenable
B. subtilis 168, eventually transferred to
B. subtilis natto BEST195 for nattokinase production.
(Fig. 1. Plasmid delivery method)
In order to differentiate how different promoters result in various
amounts of NK production within the bacteria, we designed three
types of plasmids.
To prevent leakage/flow-in transcriptions, we’ve designed to place a
TλM3 terminator before the promoters.
The first, “pNK1”, includes PaprE, the native promoter of aprE in B. subtilis. This was designed to simply increase the copy number of the aprE gene in a cell and check whether our plasmid will function properly within the experiment.
Fig 2. pNK1 plasmid design
The second, “pNK2”, includes Pgrac01,[5] an IPTG-inducible promoter harboring lac operators. This was to prevent leaky expressions that might hamper cloning, and keep NK yield under control.
(Fig. 3. pNK2 promoter design)
Finally, “pNK3” includes Pgrac212,[5] a strong constitutive promoter that can yield increased production of recombinant proteins. This was aimed for extremely high levels of NK yield.
(Fig. 4. pNK3 promoter design)
Pgrac01 is an IPTG-inducible promoter and Pgrac212 is an inducer-free strong constitutive promoter, both are used for overproduction of recombinant proteins. In the referenced study, Pgrac01 could repress gene expression about 24-fold in E. coli compared to low background levels, and Pgrac212 resulted in gene expression up by 53.4%[5]. Sequence of their promoter region (-35 to +1) and the UP element are identical, but they are differentiated by the mRNA controllable stabilizing element (CoSE) attached to the 5’ end of the transcript, which enhances stability of half-lives of mRNA transcripts and allow high production levels of recombinant proteins. [6]
If plasmid is transformed into BEST195 as targeted, they should all result in higher production of nattokinase, increasing in the order of pNK1, pNK2, and pNK3.
To successfully carry out this project, we carefully planned a tactic to efficiently build our plasmids.
The sequences of the parts used in this study are listed below.
(Fig 5. Sequences of TλM3, PaprE, Pgrac01 and grac212)
To obtain a DNA fragment of aprE gene containing the terminator-promoter upstream and the terminator downstream the aprE, we decided to build primers with sequences of DNA parts (terminators, promoters). The aprE gene was amplified with the chromosomal DNA of BEST195. The vector DNA was also amplified by PCR, and then ligated by “In-Fusion” cloning. Instead of ordering custom DNAs, since this project is based on self-cloning, this method can allow us to initiate our wet lab more smoothly from a time perspective.
We built the pNK1-F, a primer that includes TλM3. Because aprE and PaprE is a sequence that originally exist in BEST195, this will create the objective insert fragment (TλM3-PaprE-aprE-TaprE) for in-fusion cloning.
However, creating a primer with TλM3 with Pgrac01/Pgrac212 will
result in a sequence that is at least more than 130 bp long, making
it an unsuitable build to conduct PCR. Thus, we decided to create
pNK1 first, which has TλM3 sequences integrated to the
vector plasmid. By PCR duplication of pNK1, partially including the
TλM3 sequences, the vector structure to create pNK2 and
pNK3 will be prepared.
At the same time, we built pNK2-F and pNK3-F, printers that each
include a part of TλM3, Pgrac01 or
Pgrac212. This will create the objective insert fragment
(TλM3-Pgrac01/Pgrac212-aprE-TaprE).
By in-fusion cloning of the duplicated vector plasmid framework with
DNA fragments attained through PCR, we will create pNK2 and pNK3.
(Fig. 6. Process of constructing plasmids)
Thus, we built a promoter with functions listed below.
(Fig 7. Primers in build 1)
Throughout our experiment, Prof. Kei Asai, an expert in B. subtilis natto, helped us with the technical aspects of engineering this unique chassis. He generously presented us with the plasmids and bacteria strains that are crucial for this study, as listed below.
The PCR fragments containing aprE were cloned into vector
pCJspc72 to create pNK1, transformed into E.coli DH5α,
extracted, and then E.coli C600. PCR was conducted on pNK1
to create pNK2 and pNK3, which were similarly transformed into
E. coli DH5α.
The plasmid includes a spectinomycin resistance gene, so each time,
the transformed colonies can be formed by using a LB medium
containing spectinomycin at the final concentrations of 100 μg/mL.
However, we realized that primers for pNK2-F and pNK3-F were mistakenly missing spacers between the CoSE and SD sequence. Thus, we added a couple of bases and decided to call this newly designed plasmid pNK4 and pNK5. New primers were built and PCR was conducted on pNK2 and pNK3 to create the plasmid with similar functions, pNK4 and pNK5. From now on, the plasmid with Pgrac01 will be called pNK4, and plasmid with Pgrac01 will be called pNK5.
(Fig 8. Rebuilt primers for pNK2 and pNK3, which are from now on pNK4 and pNK5. )
(Fig 9. Snapgene diagrams of pCJspc72, pNK1, pNK4, and pNK5. RFP in the original plasmid (pCJspc72) is replaced by aprE.)
After In-Fusion, pNK4 and pNK5 were transformed into E.coli DH5α. In the initial plan, lacI gene had to be cloned into pNK4, that is because B. subtilis natto has no genes encoding lacI repressor. However, due to lack of time, it was getting difficult to clone lacI gene into pNK4. We decided to allocate our laboratory experiment time prioritizing to create a strain with pNK1 and pNK5, and leave pNK4 to come back to later on.
After transformation of pNK1 and pNK5 into B. subtilis 168, conjugational transfer to B. subtilis natto BEST195 was conducted.
(Fig. 10. Conjugational transfer of plasmids)
To test nattokinase yield, we adopted the fibrin plate assay. When NK producing cells, such as our BEST195, are placed on the fibrin-rich testing medium, the NK will degrade them and create a transparent halo. Relative NK amounts were determined by diameters of the halo, along with dry lab modeling techniques. This quick testing allowed us to visibly confirm the results fairly easily.
First, we used filter membrane disks, dipped them in the cultures
and placed them onto fibrin plates.
We also made natto beans with soybeans and the cell cultures, and
placed them directly onto fibrin plates.
(Fig. 11. Natto produced using soybeans and B.subtilis natto BEST195)
Our goal was to measure the distances between the edge of the colony formed around the bean and the edge of the halo created, and estimate the relative NK production of each strain when cultured with soybean protein.
(Fig. 12. Fibrin plates with filter membrane disks after 24 hours)
We found that the filter membranes failed to produce highly visible halos, and decided that it would be difficult to measure the effectiveness of our plasmids with this method.
(Fig. 13. Fibrin plate with natto bean after 24-hour culture)
We also found that placing a natto bean directly onto the fibrin plate was insufficient in terms of accuracy. Some liquid on the surface from the medium mixed with the culture, and spread in different directions on the plate, and thus we concluded that this method was too error-prone.
We devised another method for the fibrin assay, in which we made
holes of approximately 2 mm in diameter using large orifice pipette
tips, and injected equal amounts of samples. We prepared three
different types of samples.
First, the strains we wanted to use to test were cultured in NB and
LB liquid medium overnight. Then the samples were diluted to equal
OD of 0.5 (= 4 x 10^8 cells/mL) to ensure that there were equal
amounts of cells, and equal amounts of the diluted samples (4 μL;
1.6 x 10^6 cells) were injected into the holes. This method was more
accurate since there were equal amounts of cells and therefore it
would be possible to compare the relative amounts of NK produced per
cell.
We also used the natto produced with the different strains to test
NK production. The natto were placed in a tube with equal amounts of
NB liquid medium and mixed. The samples were similarly diluted to
equal OD of 0.5 (= 4 x 10^8 cells/mL) and each 4 μL was injected
into the holes.
The NB and LB cultures produced results that were both precise and accurate to the expected relative values.
(Fig. 14. Fibrin plates with NB culture of S903 strains after 24-hour culture)
However, the natto suspension liquid samples failed to show
consistent results.
During the experiment, we also noted that some samples showed
abnormally high OD relative to others. We realized that some liquid
from the beans themselves and flaky sheets of bacteria and bean skin
formed around the natto beans may have been interfering with the OD
values, disrupting the accuracy of the measurements.
(Fig. 15. Fibrin plates with natto suspension liquid after 24-hour culture)
In conclusion, we decided that the fibrin plate assay using liquid culture was the optimal method to determine NK production.
© 2024 - Content on this site is licensed under a Creative Commons Attribution 4.0 International license
The repository used to create this website is available at gitlab.igem.org/2024/grand-tokyo.